Theophylline Tablet, Extended Release
Product Images NDC 82638-106

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 82638-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harman Finochem Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Theophylline 300mg)

Label for Theophylline Extended-Release Tablets 300 mg, containing 100 tablets. The label includes dosage form and strength, manufacturer Harman Finochem Limited, storage instructions at 20°-25°C (68°-77°F), and notes on dispensing in a child-resistant container. The label also displays the National Drug Code (NDC) 82638-105-02 and the Harman logo.*

FDA Label Image

Image Description (Theophylline 450mg)

Theophylline Extended-Release Tablets 450 mg oral tablets label shows 100 tablets per package. The label includes storage instructions at 20°-25°C, manufacturer Harman Finochem Limited in India, and indicates prescription-only use. The label displays the NDC code 82638-106-02 and the Harman logo.*

FDA Label Image

Image Description (Theophylline Structure)

Chemical structure of the active ingredient Theophylline, showing a xanthine derivative with methyl groups and nitrogen atoms in its ring structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.